Cargando…
Profiling the Biophysical Developability Properties of Common IgG1 Fc Effector Silencing Variants
Therapeutic antibodies represent the most significant modality in biologics, with around 150 approved drugs on the market. In addition to specific target binding mediated by the variable fragments (Fvs) of the heavy and light chains, antibodies possess effector functions through binding of the const...
Autores principales: | Pejchal, Robert, Cooper, Anthony B., Brown, Michael E., Vásquez, Maximiliano, Krauland, Eric M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526015/ https://www.ncbi.nlm.nih.gov/pubmed/37753968 http://dx.doi.org/10.3390/antib12030054 |
Ejemplares similares
-
Functional, Biophysical, and Structural Characterization of Human IgG1 and IgG4 Fc Variants with Ablated Immune Functionality
por: Tam, Susan H., et al.
Publicado: (2017) -
IgG Fc engineering to modulate antibody effector functions
por: Wang, Xinhua, et al.
Publicado: (2017) -
Structure and Fc-Effector Function of Rhesusized Variants of Human Anti-HIV-1 IgG1s
por: Tolbert, William D., et al.
Publicado: (2022) -
Biophysical Characterization of the Contribution of
the Fab Region to the IgG-FcγRIIIa Interaction
por: Kosuge, Hirofumi, et al.
Publicado: (2022) -
Role of Fc Core Fucosylation in the Effector Function of IgG1 Antibodies
por: Golay, Josée, et al.
Publicado: (2022)